Literature DB >> 2297347

Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant.

J J Zwaginga1, J J Sixma, P G de Groot.   

Abstract

Previous studies have indicated that activation of endothelial cells may lead to the production of tissue factor. We have studied the effect of endothelial cell activation and subsequent tissue factor synthesis on thrombus formation on the extracellular matrix in flowing blood. Endothelial cells were stimulated with tumor necrosis factor, endotoxin, or phorbol ester. Coverslips with activated cells or their extracellular matrix were introduced into a perfusion system and exposed to blood anticoagulated with 20 U/ml low molecular weight heparin. This concentration allowed manipulation of blood without activation of the coagulation cascade. Platelet deposition and fibrin formation were evaluated by morphometry, and fibrinopeptide A formation was assayed as a measure of thrombin generation. Activation of endothelial cells caused fibrinopeptide A generation in the perfusate and some deposition of fibrin on endothelial cells; however, platelets were not deposited. The matrix of the stimulated endothelium also caused enhanced fibrinopeptide A generation, and platelet aggregates and fibrin were deposited on the matrix. Maximal effects were observed with stimulation periods between 4 and 10 hours and were still clearly present after 18 hours. Increase in shear rate, perfusion time, and platelet number resulted in an increase in platelet adhesion, but platelet aggregate formation as a percentage of adhesion remained constant. Platelet aggregate formation and fibrinopeptide A generation were inhibited with antibodies against tissue factor or factor VIIa. Platelet aggregate formation alone was inhibited by antibodies against glycoprotein IIb/IIIa. Polymerization of fibrin on the matrix was best supported in perfusions at a low shear rate. The new in vitro thrombosis model presented here provides a powerful tool for study of the regulation of thrombogeneity by the vessel wall in response to various stimuli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297347     DOI: 10.1161/01.atv.10.1.49

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  12 in total

Review 1.  Infusible platelet membrane as a platelet substitute for transfusion: an overview.

Authors:  Saleh Nasiri
Journal:  Blood Transfus       Date:  2013-05-14       Impact factor: 3.443

Review 2.  Shear-dependence of endothelial functions.

Authors:  W H Reinhart
Journal:  Experientia       Date:  1994-02-15

Review 3.  Utility of microfluidic devices to study the platelet-endothelium interface.

Authors:  Jevgenia Zilberman-Rudenko; Joanna L Sylman; Kathleen S Garland; Cristina Puy; Andrew D Wong; Peter C Searson; Owen J T McCarty
Journal:  Platelets       Date:  2017-03-30       Impact factor: 3.862

4.  A vascular injury model using focal heat-induced activation of endothelial cells.

Authors:  J L Sylman; D T Artzer; K Rana; K B Neeves
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

Review 5.  Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems.

Authors:  Polina G Rudakovskaya; Roman A Barmin; Pavel S Kuzmin; Elena P Fedotkina; Alexander N Sencha; Dmitry A Gorin
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

6.  Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.

Authors:  D Kirchhofer; T B Tschopp; P Hadváry; H R Baumgartner
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

Authors:  J J Zwaginga; H A Koomans; J J Sixma; T J Rabelink
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Increased platelet deposition on atherosclerotic coronary arteries.

Authors:  G H van Zanten; S de Graaf; P J Slootweg; H F Heijnen; T M Connolly; P G de Groot; J J Sixma
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Functional factor XIII-A is exposed on the stimulated platelet surface.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Steven R Fraser; Claire S Whyte; Nuala A Booth; Nicola J Mutch
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

10.  Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity.

Authors:  M Rosa Hernández; Patricia Urbán; Elisenda Casals; Joan Estelrich; Ginés Escolar; Ana M Galán
Journal:  Int J Nanomedicine       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.